Widespread noncompliance with federal cost-sharing rules exists, particularly impacting Medicare beneficiaries and ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

Patients can benefit both financially and clinically by enrolling in ongoing clinical trials, said Eric Lander, MD.

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

It's a critical time to spotlight the dire health disparities affecting Black Americans, from premature deaths to maternal ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

FDA approves Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

Making clinical trials easier to find for clinicians and making protocols for entering clinical trials more lenient can help ...

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients ...

Early trials found that both garadacimab and sebetralstat were safe when used in patients living with hereditary angioedema, ...

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...